Report #2825825

Overview

Sex

Female

Age

Age unknown

State

AR

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

A 4 months old female patient received a dose of Kinrix; Kinrix was administered for the 2nd dose of DTaP and IPV; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 42Y93, expiry date 05-JUN-2026) for prophylaxis. On an unknown date, the patient received the 2nd dose of Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: A 4 months old female patient received a dose of Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Kinrix was administered for the 2nd dose of DTaP and IPV). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 04-FEB-2025 The reporter reported that a 4 months old patient received Kinrix and Kinrix was administered for the 2nd dose of DTaP and IPV, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. And wanted to know if there was anything if they should do.